Canadian Dental Association Validates Advil PLUS Acetaminophen for Dental Pain Relief
June 9, 2025 - Ottawa, ON: The Canadian Dental Association (CDA) has awarded the CDA Seal to Advil® PLUS Acetaminophen (APA), making it the first analgesic to receive this prestigious recognition. The Seal confirms that Advil PLUS Acetaminophen provides fast, effective relief of dental pain for up to 8 hours.
Advil PLUS Acetaminophen provides 250mg of ibuprofen and 500mg of acetaminophen per dose. By combining the benefits of both ibuprofen and acetaminophen, APA offers a safer solution for acute dental pain. In addition to dental pain, it is also indicated for the relief of various conditions including headaches, muscle and joint pain, backaches, menstrual pain, and fever reduction.
Over-the-counter products like ibuprofen and acetaminophen are widely recognized as safe alternatives to opioids1 2, which carry significant risks such as addiction, overdose, and other serious side effects. The combination of ibuprofen and acetaminophen in APA can provide effective pain relief without addiction risks.
“The CDA Seal helps consumers recognize which oral health product claims are supported by scientific evidence and also supports dental professionals in making informed recommendations for their patients’ unique oral care needs,” said CDA President, Dr. Bruce Ward. “We are pleased to award Advil PLUS Acetaminophen with the Seal. This product provides a fast and effective solution for dental pain.”
Established in the 1970s, the CDA Seal was initially designed to help the public and dental professionals make informed choices by providing information on the therapeutic value of certain toothpastes. Over the years, the program has expanded to educate consumers on the oral health benefits of a variety of products.
Haleon is the parent company behind Advil PLUS Acetaminophen, and has built a reputation for trusted science and innovation.
1Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults Carrasco-Labra, Alonso et al. The Journal of the American Dental Association, Volume 155, Issue 2, 102 - 117.e9 2Kushner, P., McCarberg, B. H., Wright, W. L., Aldoori, W., Gao, P., Iqbal, A., & Petruschke, R. (2024). Ibuprofen/acetaminophen fixed-dose combination as an alternative to opioids in management of common pain types. Postgraduate Medicine, 136(6), 594–602. https://doi.org/10.1080/00325481.2024.2382671
About the Canadian Dental Association
The Canadian Dental Association (CDA) is a trusted national voice for dentists and leader working to improve the oral health of all people living in Canada. We promote oral health, support our members, and advance the dental profession. Founded in 1902, CDA has no regulatory role and is a federally incorporated not-for-profit organization whose corporate members are Canada’s provincial and territorial dental associations (PTDAs). We represent over 21,000 practising dentists nationwide and are a trusted brand and source of information about oral health and the dental profession on national and international issues.
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Voltaren, NeoCitran, Polident, and Centrum - are built on trusted science, innovation and deep human understanding.
Media Contacts:
MediaCanada@haleon.com
Haleon Canada
media@cda-adc.ca
Canadian Dental Association
